As of Sep 29
| +0.02 / +0.96%|
The 1 analysts offering 12-month price forecasts for Repros Therapeutics Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +136.97% increase from the last price of 2.11.
The current consensus among 2 polled investment analysts is to Buy stock in Repros Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.